News Conference News VIVA 2016 Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option L.A. McKeown October 12, 2016
News Conference News VIVA 2016 Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions L.A. McKeown September 22, 2016
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016